Autonomix Medical to effect 1-for-20 reverse stock split effective Oct 24, 2024

Autonomix Medical, Inc.

Stockholders approved reverse split ratio range 1:2 to 1:50; board selected 1:20.
Reverse split effective 11:59 pm ET Oct 24, 2024; Nasdaq trading post-split begins Oct 25 under AMIX.
Outstanding shares reduce from ~23.0 million to ~1.15 million; authorized shares remain 500 million.
No fractional shares issued; holders of fractional shares will receive rounding up to nearest whole share.
Proportionate adjustments to exercise prices and shares for options, warrants, and convertible notes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Autonomix Medical, Inc.: Approved an amendment to the certificate of incorporation to effect a 1-for-20 reverse stock split of common stock (effective 2024-10-24).

Change: charter amendment
Effective: 2024-10-24

Exact text from the filing

The Amendment was filed with the Secretary of State of the State of Delaware and the Reverse Stock Split will become effective in accordance with the terms of the Amendment at 11:59 p.m. Eastern Time on October 24, 2024 (the “Effective Time”), and the Company’s common stock will open for trading on The Nasdaq Capital Market on October 25, 2024 on a post-split basis, under the existing ticker symbol “AMIX” but with a new CUSIP number 05330T205.

View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

Autonomix Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-032175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.